Spots Global Cancer Trial Database for Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment
Official Title: A Phase II Study Testing the Safety and Activity of AGS-003 as an Immunotherapeutic in Subjects With Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination With Sunitinib
Study ID: NCT00678119
Conditions
Study Description
Brief Summary: Study to investigate an anticancer cellular immunotherapeutic, AGS-003, when used in combination with sunitinib in subjects with previously untreated advanced stage RCC.
Detailed Description: The purpose of this study is to investigate an anticancer immunotherapeutic, AGS-003, when used in combination with sunitinib (the treatment regimen) in a single-stage, Phase II design in subjects with previously untreated advanced stage RCC after nephrectomy/excisional biopsy/metastasectomy. AGS-003 is formulated using mature DCs co-electroporated with CD40L IVT RNA and autologous total tumor RNA
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope, Duarte, California, United States
UCLA, Los Angeles, California, United States
The Urology Center of Colorado, Denver, Colorado, United States
Emory University, Atlanta, Georgia, United States
The Indiana University Cancer Center, Indianapolis, Indiana, United States
University of Iowa, Iowa City, Iowa, United States
University of Kansas Hospital, Kansas City, Kansas, United States
University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
Carolina's Medical Center / Blumenthal Cancer Center, Charlotte, North Carolina, United States
Barrett Cancer, Cincinnati, Ohio, United States
CORTPA, Dallas, Texas, United States
Urology of Virginia-Sentara Medical Group, Norfolk, Virginia, United States
Princess Margaret Hospital, Toronto, Ontario, Canada
Jewish General Hospital, Montreal, Quebec, Canada
Contact Details
Name: Fred Miesowicz
Affiliation: Argos Therapeutics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
